Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ITRM Iterum Therapeutics PLC

0.13 (9.09%)
Apr 22 2024 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 197,643
Bid Price 1.54
Ask Price 1.58
News -
Day High 1.60


52 Week Range


Day Low 1.46
Company Name Stock Ticker Symbol Market Type
Iterum Therapeutics PLC ITRM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.13 9.09% 1.56 17:27:12
Open Price Low Price High Price Close Price Prev Close
1.46 1.46 1.60 1.58 1.43
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
549 197,643 $ 1.55 $ 307,080 - 0.622 - 2.64
Last Trade Time Type Quantity Stock Price Currency
17:26:55 formt 150 $ 1.56 USD

Iterum Therapeutics PLC Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
21.23M 13.44M - 503k -43.67M -3.25 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Iterum Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No ITRM Message Board. Create One! See More Posts on ITRM Message Board See More Message Board Posts

Historical ITRM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.581.631.421.4792,389-0.02-1.27%
1 Month1.591.931.421.66154,681-0.03-1.89%
3 Months1.712.641.21971.57659,613-0.15-8.77%
6 Months0.672.640.6221.60392,6550.89132.84%
1 Year1.072.640.6221.55216,6620.4945.79%
3 Years1.143.13050.1750.98717722,524,3200.4236.84%
5 Years8.188.460.1751.353,472,748-6.62-80.93%

Iterum Therapeutics Description

Iterum Therapeutics PLC is a pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents.

Your Recent History

Delayed Upgrade Clock